Symbol="ALNY"
AssetType="Common Stock"
Name="Alnylam Pharmaceuticals Inc"
Description="Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing and commercializing RNA interference (RNAi) therapies. The company is headquartered in Cambridge, Massachusetts."
CIK="1178670"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="24275100000"
EBITDA="-739073984"
PERatio="None"
PEGRatio="-0.49"
BookValue="-2.087"
DividendPerShare="0"
DividendYield="0"
EPS="-8.74"
RevenuePerShareTTM="9.32"
ProfitMargin="-0.931"
OperatingMarginTTM="-0.689"
ReturnOnAssetsTTM="-0.144"
ReturnOnEquityTTM="-15.01"
RevenueTTM="1143449000"
GrossProfitTTM="868601000"
DilutedEPSTTM="-8.74"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.497"
AnalystTargetPrice="248.69"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="29.37"
PriceToBookRatio="142.92"
EVToRevenue="28.64"
EVToEBITDA="-29.42"
Beta="0.482"
num_52WeekHigh="242.97"
num_52WeekLow="138.18"
num_50DayMovingAverage="194.95"
num_200DayMovingAverage="206.67"
SharesOutstanding="124526000"
DividendDate="None"
ExDividendDate="None"
symbol="ALNY"
open="196.18"
high="196.54"
low="192.58"
price="194.87"
volume="853862.00"
latest_trading_day="2023-07-27"
previous_close="194.94"
change="-0.07"
change_percent="-0.0359%"
aroon_positive_momentum_days="28"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="28"
Volume_recent_avg="674148"
Change_recent_avg="-0.24"
Delta_recent_avg="5.68"
Variance_recent_avg="2.84"
Change_ratio_recent_avg="-0.14"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="28"
Aroon_momentum_negative="72"
image_negative_thumbnail_id_1="170"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0006.jpeg"
image_negative_thumbnail_id_2="1106"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0139.jpeg"
image_neutral_thumbnail_id_1="537"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0062.jpeg"
image_neutral_thumbnail_id_2="543"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0056.jpeg"
image_positive_thumbnail_id_1="970"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0132.jpeg"
image_positive_thumbnail_id_2="691"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0017.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1200"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
